Found: 106
Select item for more details and to access through your institution.
Pre-clinical Study of <sup>213</sup>Bi Labeled PAI2 for the Control of Micrometastatic Pancreatic Cancer.
- Published in:
- Clinical & Experimental Metastasis, 2005, v. 22, n. 7, p. 575, doi. 10.1007/s10585-005-5788-9
- By:
- Publication type:
- Article
Influence of tumour size on the efficacy of targeted alpha therapy with Bi-[DOTA,Tyr]-octreotate.
- Published in:
- EJNMMI Research, 2016, v. 6, n. 1, p. 1, doi. 10.1186/s13550-016-0162-2
- By:
- Publication type:
- Article
Magnetic Memory Effect in a Transuranic Mononuclear Complex.
- Published in:
- Angewandte Chemie International Edition, 2011, v. 50, n. 7, p. 1696, doi. 10.1002/anie.201006619
- By:
- Publication type:
- Article
[An(H<sub>2</sub>O)<sub>9</sub>](CF<sub>3</sub>SO<sub>3</sub>)<sub>3</sub> (An=U-Cm, Cf): Exploring Their Stability, Structural Chemistry, and Magnetic Behavior by Experiment and Theory.
- Published in:
- Angewandte Chemie International Edition, 2010, v. 49, n. 36, p. 6343, doi. 10.1002/anie.201001077
- By:
- Publication type:
- Article
Cover Picture: [An(H<sub>2</sub>O)<sub>9</sub>](CF<sub>3</sub>SO<sub>3</sub>)<sub>3</sub> (An=U-Cm, Cf): Exploring Their Stability, Structural Chemistry, and Magnetic Behavior by Experiment and Theory (Angew. Chem. Int. Ed. 36/2010).
- Published in:
- Angewandte Chemie International Edition, 2010, v. 49, n. 36, p. 6229, doi. 10.1002/anie.201003226
- By:
- Publication type:
- Article
In vitro evaluation of <sup>225</sup>Ac‐DOTA‐substance P for targeted alpha therapy of glioblastoma multiforme.
- Published in:
- Chemical Biology & Drug Design, 2018, v. 92, n. 1, p. 1344, doi. 10.1111/cbdd.13199
- By:
- Publication type:
- Article
Evaluation of the tolerability and safety of [<sup>225</sup>Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11900-y
- By:
- Publication type:
- Article
Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with 225Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer.
- Published in:
- Molecules, 2020, v. 25, n. 5, p. 1025, doi. 10.3390/molecules25051025
- By:
- Publication type:
- Article
First‐Generation Bispidine Chelators for <sup>213</sup>Bi<sup>III</sup> Radiopharmaceutical Applications.
- Published in:
- ChemMedChem, 2020, v. 15, n. 16, p. 1591, doi. 10.1002/cmdc.202000361
- By:
- Publication type:
- Article
Intravesical α-Radioimmunotherapy with <sup>213</sup>Bi-Anti-EGFR-mAb Defeats Human Bladder Carcinoma in Xenografted Nude Mice.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 10, p. 1700, doi. 10.2967/jnumed.109.065961
- By:
- Publication type:
- Article
Comparative Analysis of Morphological and Functional Effects of 225 Ac- and 177 Lu-PSMA Radioligand Therapies (RLTs) on Salivary Glands.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 23, p. 16845, doi. 10.3390/ijms242316845
- By:
- Publication type:
- Article
Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 21, p. 15701, doi. 10.3390/ijms242115701
- By:
- Publication type:
- Article
Zur Elektronenstruktur metallorganischer Komplexe der f-Elemente. 60 [1] Strukturelle, einkristalloptische und magnetooptische Untersuchungen von Trialkylphosphat-Addukten des Grundkörpers Tris(cyclopentadienyl)lanthanid(III) (Ln = La, Pr) sowie Ergebnisse vergleichender optischer Studien an [Pr(Ind)<sub>3</sub>(OP(OEt)<sub>3</sub>)] (Ind = Indenyl)
- Published in:
- Zeitschrift für Anorganische und Allgemeine Chemie, 2004, v. 630, n. 6, p. 928, doi. 10.1002/zaac.200400044
- By:
- Publication type:
- Article
DNA damage in human whole blood caused by radiopharmaceuticals evaluated by the comet assay.
- Published in:
- Mutagenesis, 2019, v. 34, n. 3, p. 239, doi. 10.1093/mutage/gez007
- By:
- Publication type:
- Article
Tris‐{hydridotris(1‐pyrazolyl)borato}actinide Complexes: Synthesis, Spectroscopy, Crystal Structure, Bonding Properties and Magnetic Behaviour.
- Published in:
- Chemistry - A European Journal, 2020, v. 26, n. 49, p. 11293, doi. 10.1002/chem.202001095
- By:
- Publication type:
- Article
Prostat Kanserinin Hedefe Yönelik Alfa-Radyonüklit Tedavisinde Ac-225-PSMA'nın In Vitro ve In Vivo Değerlendirilmesi.
- Published in:
- Nuclear Medicine Seminars, 2019, v. 5, p. 3
- By:
- Publication type:
- Article
Radio-immunothérapie alpha.
- Published in:
- Médecine Sciences, 2016, v. 32, n. 4, p. 362, doi. 10.1051/medsci/20163204014
- By:
- Publication type:
- Article
Deescalated <sup>225</sup>Ac-PSMA-617 Versus <sup>177</sup>Lu/<sup>225</sup>Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267206
- By:
- Publication type:
- Article
Deescalated <sup>225</sup>Ac-PSMA-617 Versus <sup>177</sup>Lu/<sup>225</sup>Ac-PSMA-617 Cocktail Therapy: A Single-Center Retrospective Analysis of 233 Patients.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 7, p. 1057, doi. 10.2967/jnumed.123.267206
- By:
- Publication type:
- Article
Clinical Translation of Targeted α-Therapy: An Evolution or a Revolution?
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 685, doi. 10.2967/jnumed.122.265353
- By:
- Publication type:
- Article
Targeted α-Therapy Using <sup>225</sup>Ac Radiolabeled Single-Domain Antibodies Induces Antigen-Specific Immune Responses and Instills Immunomodulation Both Systemically and at the Tumor Microenvironment.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 5, p. 751, doi. 10.2967/jnumed.122.264752
- By:
- Publication type:
- Article
mCRPC patients receiving 225Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
mCRPC patients receiving <sup>225</sup>Ac-PSMA-617 therapy in post androgen deprivation therapy setting: Response to treatment and survival analysis.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 3, p. 1, doi. 10.2967/jnumed.121.263618
- By:
- Publication type:
- Article
Production and supply of alpha particles emitting radionuclides for Targeted Alpha Therapy (TAT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.261016
- By:
- Publication type:
- Article
Production and supply of alpha particles emitting radionuclides for Targeted Alpha Therapy (TAT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.261016
- By:
- Publication type:
- Article
Production and supply of alpha particles emitting radionuclides for Targeted Alpha Therapy (TAT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.261016
- By:
- Publication type:
- Article
Production and supply of alpha particles emitting radionuclides for Targeted Alpha Therapy (TAT).
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.261016
- By:
- Publication type:
- Article
Patients resistant against PSMA-targeting alpha-radiation therapy often harbor mutations in DNA-repair associated genes.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.234559
- By:
- Publication type:
- Article
Concise title: PREDICTORS OF OVERALL AND DISEASE FREE SURVIVAL IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS RECEIVING 225Ac-PSMA-617 RADIOLIGAND THERAPY.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229229
- By:
- Publication type:
- Article
New Developments in Peptide Receptor Radionuclide Therapy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 2, p. 167, doi. 10.2967/jnumed.118.213496
- By:
- Publication type:
- Article
Radiolabeled Antibodies Against Müllerian-Inhibiting Substance Receptor, Type II: New Tools for a Theranostic Approach in Ovarian Cancer.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 8, p. 1234, doi. 10.2967/jnumed.118.208611
- By:
- Publication type:
- Article
Targeted a-Therapy of Metastatic Castration-Resistant Prostate Cancer with <sup>225</sup>Ac-PSMA-617: Swimmer-Plot Analysis Suggests Efficacy Regarding Duration of Tumor Control.
- Published in:
- Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 795, doi. 10.2967/jnumed.117.203539
- By:
- Publication type:
- Article
Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with <sup>225</sup>Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 10, p. 1624, doi. 10.2967/jnumed.117.191395
- By:
- Publication type:
- Article
The Future of Radioligand Therapy: α, β, or Both?
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 7, p. 1017, doi. 10.2967/jnumed.117.190124
- By:
- Publication type:
- Article
α- Versus β-Emitting Radionuclides for Pretargeted Radioimmunotherapy of Carcinoembryonic Antigen--Expressing Human Colon Cancer Xenografts.
- Published in:
- Journal of Nuclear Medicine, 2017, v. 58, n. 6, p. 926, doi. 10.2967/jnumed.116.187021
- By:
- Publication type:
- Article
<sup>225</sup>Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 12, p. 1941, doi. 10.2967/jnumed.116.178673
- By:
- Publication type:
- Article
Utilizing High-Energy γ-Photons for High-Resolution <sup>213</sup>Bi SPECT in Mice.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 3, p. 486, doi. 10.2967/jnumed.115.157685
- By:
- Publication type:
- Article
Anti-Prostate-Specific Membrane Antigen Liposomes Loaded with <sup>225</sup>Ac for Potential Targeted Antivascular α-Particle Therapy of Cancer.
- Published in:
- Journal of Nuclear Medicine, 2014, v. 55, n. 1, p. 107, doi. 10.2967/jnumed.113.125476
- By:
- Publication type:
- Article
<sup>213</sup>Bi Radioimmunotherapy with an Anti-mCD138 Monoclonal Antibody in a Murine Model of Multiple Myeloma.
- Published in:
- Journal of Nuclear Medicine, 2013, v. 54, n. 9, p. 1597, doi. 10.2967/jnumed.112.111997
- By:
- Publication type:
- Article
Magnetic Memory Effect in a Transuranic Mononuclear Complex.
- Published in:
- Angewandte Chemie, 2011, v. 123, n. 7, p. 1734, doi. 10.1002/ange.201006619
- By:
- Publication type:
- Article
[An(H<sub>2</sub>O)<sub>9</sub>](CF<sub>3</sub>SO<sub>3</sub>)<sub>3</sub> (An=U-Cm, Cf): Exploring Their Stability, Structural Chemistry, and Magnetic Behavior by Experiment and Theory.
- Published in:
- Angewandte Chemie, 2010, v. 122, n. 36, p. 6487, doi. 10.1002/ange.201001077
- By:
- Publication type:
- Article
Titelbild: [An(H<sub>2</sub>O)<sub>9</sub>](CF<sub>3</sub>SO<sub>3</sub>)<sub>3</sub> (An=U-Cm, Cf): Exploring Their Stability, Structural Chemistry, and Magnetic Behavior by Experiment and Theory (Angew. Chem. 36/2010).
- Published in:
- Angewandte Chemie, 2010, v. 122, n. 36, p. 6367, doi. 10.1002/ange.201003226
- By:
- Publication type:
- Article
Advances in targeted alpha therapy of cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 51, n. 5, p. 1205, doi. 10.1007/s00259-024-06658-1
- By:
- Publication type:
- Article
PSMA-based alpha therapy in prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2023, v. 50, n. 12, p. 3506, doi. 10.1007/s00259-023-06384-0
- By:
- Publication type:
- Article
DNA Double Strand Breaks as Predictor of Efficacy of the Alpha-Particle Emitter Ac-225 and the Electron Emitter Lu-177 for Somatostatin Receptor Targeted Radiotherapy.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0088239
- By:
- Publication type:
- Article
Alpha-Particle Emitting <sup>213</sup>Bi-Anti-EGFR Immunoconjugates Eradicate Tumor Cells Independent of Oxygenation
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064730
- By:
- Publication type:
- Article